Understanding LACC1-Associated Juvenile Arthritis
At a Glance
LACC1-associated juvenile arthritis is a rare inherited condition caused by changes in the LACC1 gene. It often starts very early, can cause severe joint inflammation and damage, and genetic testing helps distinguish it from more common childhood arthritis.
Learning that your child has a rare genetic condition can be overwhelming, especially when the name—LACC1-associated juvenile arthritis—is likely one you have never heard before. Because this condition is so rare, it is common for local pediatricians or even some rheumatologists to have limited experience with it [1]. In medical literature, there are only small groups of patients—often just a few dozen at a time—identified globally [2][3].
This condition is a monogenic autoinflammatory disorder. “Monogenic” means it is caused by a variation in a single gene (the LACC1 gene), rather than a complex mix of genetics and environment like most types of juvenile idiopathic arthritis (JIA) [2]. “Autoinflammatory” means the body’s innate immune system—its first-line defense—is misfiring and causing dysregulated inflammation without a clear external trigger [4]. Note: Because treatment often involves immunosuppressive medications, always follow your medical team’s plan for managing fevers and suspected infections, as the immune system’s defenses will be lowered.
The Role of the LACC1 Gene and FAMIN
To understand this condition, it helps to think of the LACC1 gene as a set of instructions for building a protein called FAMIN [5]. This protein is found mostly in macrophages, which are immune cells that act like the “clean-up crew” and “sentries” of the body [5][6].
In children with this condition, the LACC1 gene has a defect that prevents it from making a functional FAMIN protein. This “loss of function” disrupts several vital processes inside the immune cells. Experimental studies propose several mechanisms for how this causes disease:
- Metabolism and Energy: FAMIN helps macrophages manage their energy. Without it, these cells have trouble processing lipids (fats) and managing their “batteries” (mitochondria) [5].
- The Recycling System (Autophagy): FAMIN is involved in autophagy, a process where cells break down and recycle old or damaged parts. When this system fails in experimental models, it can lead to cellular stress and inflammation [5].
- Inflammatory Signaling: In some laboratory models, when FAMIN is missing, the immune cells may overproduce inflammatory chemicals, such as cytokines like IL-6, which contribute to the fevers and joint swelling seen in patients, although individual cytokine profiles can vary [7].
How It Differs from Typical Arthritis
Because this is a genetic disease, it often follows an autosomal recessive pattern. This means a child usually inherits one copy of the changed gene from each parent. The parents typically have no symptoms themselves but are “carriers” [2][1].
While it can look like common systemic juvenile idiopathic arthritis (sJIA) or polyarticular JIA (which affects many joints), there are specific clues that point toward a LACC1 defect:
- Very Early Onset: Symptoms often begin in infancy or very early childhood. In the largest reported cohort of 43 patients, 86% were classified as early-onset [8][2].
- Severe Joint Damage: This condition is frequently “erosive,” meaning the inflammation can wear down the bone and cartilage in the joints more aggressively than other forms of arthritis [2][8].
- Limb Swelling: About 23% of children in that reported 43-patient cohort experienced lymphedema, which is persistent swelling in the arms or legs [2]. However, any persistent limb swelling must be medically evaluated to distinguish it from joint synovitis, soft-tissue inflammation, or infection.
Navigating a Rare Diagnosis
Validating your child’s symptoms through genetic testing is a major step forward. Because this condition can mimic other forms of arthritis, it is often misdiagnosed initially. Knowing the genetic cause allows your medical team to narrow the diagnosis and inform individualized decisions that specifically target the autoinflammatory nature of the disease [4][2].
If your child’s doctors seem unfamiliar with LACC1, it is because the medical community’s understanding of this gene is relatively new, with much of the research being published only in the last decade [3]. Seeking care at a major academic research center or a hospital with a specialized pediatric autoinflammatory clinic can help ensure your child is managed by experts who follow the latest genetic findings.
Common questions in this guide
What is LACC1-associated juvenile arthritis?
How can a LACC1 gene change cause inflammation?
What signs may occur in children with LACC1-associated juvenile arthritis?
How is LACC1-associated juvenile arthritis confirmed?
Is LACC1-associated juvenile arthritis inherited?
Why should families seek specialist care for LACC1-associated arthritis?
How might an LACC1 diagnosis change my child's treatment?
Get notified when new evidence is published on juvenile arthritis due to defect in LACC1.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (8)
- 1
Clinical characteristics and genotype analysis of a Chinese patient with juvenile arthritis due to novel LACC1 frameshift mutation and literature review.
Wu Y, Wang S, Yin W, et al.
Molecular genetics & genomic medicine 2023; (11(7)):e2175 doi:10.1002/mgg3.2175.
PMID: 37186377 - 2
New or vanishing frontiers: LACC1-associated juvenile arthritis.
Al-Mayouf SM, Yateem M, Al-Dusery H, et al.
International journal of pediatrics & adolescent medicine 2021; (8(1)):44-47 doi:10.1016/j.ijpam.2020.11.005.
PMID: 33718577 - 3
Pattern and diagnostic evaluation of systemic autoinflammatory diseases other than familial Mediterranean fever among Arab children: a multicenter study from the Pediatric Rheumatology Arab Group (PRAG).
Al-Mayouf SM, Almutairi A, Albrawi S, et al.
Rheumatology international 2020; (40(1)):49-56 doi:10.1007/s00296-019-04478-3.
PMID: 31741047 - 4
A novel LACC1 variant c.658G>A (p. Asp220Asn) in familial juvenile arthritis: identification and functional analysis.
Alblooshi H, Mustafa N, Khalam AA, et al.
Human genomics 2025; (19(1)):85.
PMID: 40713900 - 5
LACC1 deficiency links juvenile arthritis with autophagy and metabolism in macrophages.
Omarjee O, Mathieu AL, Quiniou G, et al.
The Journal of experimental medicine 2021; (218(3)) doi:10.1084/jem.20201006.
PMID: 33606008 - 6
LACC1 Required for NOD2-Induced, ER Stress-Mediated Innate Immune Outcomes in Human Macrophages and LACC1 Risk Variants Modulate These Outcomes.
Huang C, Hedl M, Ranjan K, Abraham C
Cell reports 2019; (29(13)):4525-4539.e4 doi:10.1016/j.celrep.2019.11.105.
PMID: 31875558 - 7
LACC1 deficiency leading to juvenile arthritis and anemia.
He T, Wang L, Huang X, et al.
Clinical immunology (Orlando, Fla.) 2024; (265()):110290 doi:10.1016/j.clim.2024.110290.
PMID: 38944365 - 8
[Monogenic variants in Laccase domain-containing 1 (LACC1) as the cause of juvenile arthritis].
Knieper AM, von Stuckrad ASL, Minden K, et al.
Zeitschrift fur Rheumatologie 2024; (83(1)):4-14 doi:10.1007/s00393-023-01442-2.
PMID: 37921883
This page is for informational purposes only and does not constitute medical advice. Your child's pediatric rheumatology team should interpret LACC1 testing and guide treatment and decisions about fever or possible infection.